FASLG, TNFRSF1B, GATA3, TARDBP, ZBP1, TNFRSF21, and TLR3 are mainly expressed in multiple immune cell types, and immune cells have a role in TME to inhibit tumor progression (Simiczyjew et al., 2020). Here, TNFRSF21 is linked to neoplasm.